Advertisement

Substance Use Disorders

  • Catherine E. Paquette
  • Jessica F. Magidson
  • Surabhi Swaminath
  • Stacey B. DaughtersEmail author
Chapter

Abstract

In this chapter, we present a framework for the assessment and diagnosis of substance use disorders (SUDs) with an emphasis on integrating a dimensional, multifaceted approach into the traditional categorical system that historically underlies most established diagnostic interviewing tools. Supplementing categorical diagnoses with dimensional tools allows for a more nuanced clinical picture than simply determining whether or not an individual meets criteria for an SUD. A dimensional approach may provide further information on the frequency and degree of use, associated impairment, and comorbid symptomatology. Using such information to supplement an SUD diagnosis can enable a more individualized treatment plan that targets the psychological underpinnings of substance use as well as the consequences of use. This chapter can be used as a clinical tool for the assessment of substance use at multiple stages (screening, diagnostic assessment and dimensional assessment), encompassing a broad scope beyond traditional methods of categorical diagnosis.

Keywords

Substance use Alcohol Drugs Assessment Interviewing Dimensional approach 

References

  1. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-V) (5th ed.). Arlington, VA: American Psychiatric Association.Google Scholar
  2. Avants, S. K., Marcotte, D., Arnold, R., & Margolin, A. (2003). Spiritual beliefs, world assumptions, and HIV risk behavior among heroin and cocaine users. Psychology of Addictive Behaviors, 17(2), 159–162.Google Scholar
  3. Barry, C. L., McGinty, E. E., Pescosolido, B. A., & Goldman, H. H. (2014). Stigma, discrimination, treatment effectiveness, and policy: Public views about drug addiction and mental illness. Psychiatric Services, 65(10), 1269–1272.Google Scholar
  4. Bertholet, N., Daeppen, J. B., Wietlisbach, V., Fleming, M., & Burnand, B. (2005). Reduction of alcohol consumption by brief alcohol intervention in primary care: Systematic review and meta-analysis. Archives of Internal Medicine, 165(9), 986–995.Google Scholar
  5. Bluthenthal, R. N., Jacobson, J. O., & Robinson, P. L. (2007). Are racial disparities in alcohol treatment completion associated with racial differences in treatment modality entry? Comparison of outpatient treatment and residential treatment in Los Angeles County, 1998 to 2000. Alcoholism, Clinical and Experimental Research, 31(11), 1920–1926.Google Scholar
  6. Boardman, J. D., Finch, B. K., Ellison, C. G., Williams, D. R., & Jackson, J. S. (2001). Neighborhood disadvantage, stress, and drug use among adults. Journal of Health and Social Behavior, 42(2), 151–165.Google Scholar
  7. Boughner, E., & Frewen, P. (2016). Gender differences in perceived causal relations between trauma-related symptoms and substance use disorders in online and outpatient samples. Traumatology, 22(4), 288–298.Google Scholar
  8. Brinkman, W. B., Epstein, J. N., Auinger, P., Tamm, L., & Froehlich, T. E. (2015). Association of attention-deficit/hyperactivity disorder and conduct disorder with early tobacco and alcohol use. Drug and Alcohol Dependence, 147, 183–189.Google Scholar
  9. Broyles, L. M., Binswanger, I. A., Jenkins, J. A., Finnell, D. S., Faseru, B., Cavaiola, A., … Gordon, A. J. (2014). Confronting inadvertent stigma and pejorative language in addiction scholarship: A recognition and response. Substance Abuse, 35(3), 217–221.Google Scholar
  10. Bryant, K., Rounsaville, B., Spitzer, R., & Williams, J. (1992). Reliability of dual diagnosis: Substance dependence and psychiatric disorders. Journal of Nervous and Mental Disease, 180(4), 251–257.Google Scholar
  11. Carlson, S. R., McLarnon, M. E., & Iacono, W. G. (2007). P300 amplitude, externalizing psychopathology, and earlier- versus later-onset substance-use disorder. Journal of Abnormal Psychology, 116(3), 565–577.Google Scholar
  12. Center for Behavioral Health Statistics and Quality. (2017). 2016 National Survey on Drug Use and Health: Detailed tables. Rockville, MD: Substance Abuse and Mental Health Services Administration.Google Scholar
  13. Chen, K. W., Banducci, A. N., Guller, L., Macatee, R. J., Lavelle, A., Daughters, S., & Lejuez, C. W. (2011). An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program. Drug and Alcohol Dependence, 118(2–3), 92–99.Google Scholar
  14. Chen, P., & Jacobson, K. C. (2012). Developmental trajectories of substance use from early adolescence to young adulthood: Gender and racial/ethnic differences. Journal of Adolescent Health, 50(2), 154–163.Google Scholar
  15. Chun, S., Harris, A., Carrion, M., Rojas, E., Stark, S., Lejuez, C., … Bornovalova, M. A. (2017). A psychometric investigation of gender differences and common processes across borderline and antisocial personality disorders. Journal of Abnormal Psychology, 126(1), 76–88.Google Scholar
  16. Colpaert, K., Vanderplasschen, W., Maeyer, J. D., Broekaert, E., & Fruyt, F. D. (2012). Prevalence and determinants of personality disorders in a clinical sample of alcohol-, drug-, and dual-dependent patients. Substance Use & Misuse, 47(6), 649–661.Google Scholar
  17. Daniel, J. Z., Hickman, M., Macleod, J., Wiles, N., Lingford-Hughes, A., Farrell, M., … Lewis, G. (2009). Is socioeconomic status in early life associated with drug use? A systematic review of the evidence. Drug & Alcohol Review, 28(2), 142–153.Google Scholar
  18. Dennis, M. L., Scott, C. K., Funk, R., & Foss, M. A. (2005). The duration and correlates of addiction and treatment careers. Journal of Substance Abuse Treatment, 28(2, Supplement), S51–S62.Google Scholar
  19. Dolan, K., Rouen, D., & Kimber, J. (2004). An overview of the use of urine, hair, sweat and saliva to detect drug use. Drug & Alcohol Review, 23(2), 213–217.Google Scholar
  20. Elliott, M., & Lowman, J. (2015). Education, income and alcohol misuse: A stress process model. Social Psychiatry and Psychiatric Epidemiology, 50(1), 19–26.Google Scholar
  21. Fals-Stewart, W., O’Farrell, T., Freitas, T., McFarlin, S., & Rutigliano, P. (2000). The Timeline Followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties. Journal of Consulting and Clinical Psychology, 68(1), 134–144.Google Scholar
  22. Fergusson, D., & Horwood, L. (2002). Male and female offending trajectories. Development and Psychopathology, 14(1), 159–177.Google Scholar
  23. Finch, K. A., Ramo, D. E., Delucchi, K. L., Liu, H., & Prochaska, J. J. (2013). Subjective social status and substance use severity in a young adult sample. Psychology of Addictive Behaviors, 27(3), 901–908.Google Scholar
  24. First, M. B., Williams, J. B., Karg, R. S., & Spitzer, R. L. (2016). SCID-5-CV: Structured clinical interview for DSM-5 disorders: Clinician version. Arlington, VA: American Psychiatric Association.Google Scholar
  25. Flynn, H. A., Walton, M. A., Curran, G. M., Blow, F. C., & Knutzen, S. (2004). Psychological distress and return to substance use two years following treatment. Substance Use and Misuse, 39(6), 885–910.Google Scholar
  26. Fothergill, K., Ensminger, M. E., Doherty, E. E., Juon, H.-S., & Green, K. M. (2016). Pathways from early childhood adversity to later adult drug use and psychological distress: A prospective study of a cohort of African Americans. Journal of Health and Social Behavior, 57(2), 223–239.Google Scholar
  27. Friedman, A., Glassman, K., & Terras, A. (2001). Violent behavior as related to use of marijuana and other drugs. Journal of Addictive Diseases, 20(1), 49–72.Google Scholar
  28. Gastfriend, D. R. (Ed.). (2004). Addiction treatment matching: Research foundations of the American Society of Addiction Medicine (ASAM). Binghamton, NY: Haworth Press.Google Scholar
  29. Ghose, T. (2008). Organizational- and individual-level correlates of posttreatment substance use: A multilevel analysis. Journal of Substance Abuse Treatment, 34(2), 249–262.Google Scholar
  30. Greenfield, S. F., Brooks, A. J., Gordon, S. M., Green, C. A., Kropp, F., McHugh, R. K., … Miele, G. M. (2007). Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and Alcohol Dependence, 86(1), 1–21.Google Scholar
  31. Hagman, B. T., Kuerbis, A. N., Morgenstern, J., Bux, D. A., Parsons, J. T., & Heidinger, B. E. (2009). An Item Response Theory (IRT) Analysis of the Short Inventory of Problems-Alcohol and Drugs (SIP-AD) among non-treatment seeking men-who-have-sex-with-men: Evidence for a shortened 10-item SIP-AD. Addictive Behaviors, 34(11), 948–954.Google Scholar
  32. Hasin, D., Liu, X., Nunes, E., McCloud, S., Samet, S., & Endicott, J. (2002). Effects of major depression on remission and relapse of substance dependence. Archives of General Psychiatry, 59(4), 375–380.Google Scholar
  33. Hasin, D., Samet, S., Nunes, E., Meydan, J., Matseoane, K., & Waxman, R. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research interview for Substance and Mental Disorder for DSM-IV. American Journal of Psychiatry, 163(4), 689–696.Google Scholar
  34. Hasin, D. S., Trautman, K. D., Miele, G. M., Samet, S., Smith, M., & Endicott, J. (1996). Psychiatric Research Interview for Substance Use and Mental Disorders (PRISM): Reliability for substance abusers. American Journal of Psychiatry, 153(9), 1195–1201.Google Scholar
  35. Helzer, J. E., Kraemer, H. C., & Krueger, R. F. (2006). The feasibility and need for dimensional psychiatric diagnoses. Psychological Medicine, 36(12), 1671–1680.Google Scholar
  36. Hernandez-Avila, C. A., Rounsaville, B. J., & Kranzler, H. R. (2004). Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug and Alcohol Dependence, 74(3), 265–272.Google Scholar
  37. Hjorthoj, C. R., Hjorthoj, A. R., & Nordentoft, M. (2012). Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances – systematic review and meta-analysis. Addictive Behaviors, 37(3), 225–233.Google Scholar
  38. Hogue, A., Dauber, S., & Morgenstern, J. (2010). Validation of a contemplation ladder in an adult substance use disorder sample. Psychology of Addictive Behaviors, 24(1), 137–144.Google Scholar
  39. Hone-Blanchet, A., Ciraulo, D. A., Pascual-Leone, A., & Fecteau, S. (2015). Noninvasive brain stimulation to suppress craving in substance use disorders: Review of human evidence and methodological considerations for future work. Neuroscience and Biobehavioral Reviews, 59, 184–200.Google Scholar
  40. Hser, Y., Huang, Y., Teruya, C., & Anglin, M. D. (2004). Gender differences in treatment outcomes over a three-year period: A path model analysis. Journal of Drug Issues, 34(2), 419–440.Google Scholar
  41. International Classification of Diseases 11th Revision. (2018). Retrieved January 3, 2019, from https://icd.who.int/
  42. Jarvis, M., Williams, J., Hurford, M., Lindsay, D., Lincoln, P., Giles, L., … Safarian, T. (2017). Appropriate use of drug testing in clinical addiction medicine. Journal of Addiction Medicine, 11(3), 163–173.Google Scholar
  43. Julien, R. M. (2005). A primer of drug action (10th ed.). New York, NY: Macmillan.Google Scholar
  44. Kessler, R. C., & Ustun, T. B. (2004). The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research, 13(2), 93–121.Google Scholar
  45. Knight, K., Simpson, D., & Hiller, M. (2002). Screening and referral for substance-abuse treatment in the criminal justice system. Treatment of Drug Offenders: Policies and Issues, 14, 259–272.Google Scholar
  46. Kranzler, H. R., Kadden, R. M., Burleson, J. A., & Babor, T. F. (1995). Validity of psychiatric diagnoses in patients with substance use disorders: Is the interview more important than the interviewer? Comprehensive Psychiatry, 36(4), 278–288.Google Scholar
  47. Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1–13.Google Scholar
  48. Lee, J. O., Cho, J., Yoon, Y., Bello, M. S., Khoddam, R., & Leventhal, A. M. (2018). Developmental pathways from parental socioeconomic status to adolescent substance use: Alternative and complementary reinforcement. Journal of Youth and Adolescence, 47(2), 334–348.Google Scholar
  49. Lee, J. O., Jones, T. M., Kosterman, R., Rhew, I. C., Lovasi, G. S., Hill, K. G., … Hawkins, J. D. (2017). The association of unemployment from age 21 to 33 with substance use disorder symptoms at age 39: The role of childhood neighborhood characteristics. Drug and Alcohol Dependence, 174, 1–8, 1.Google Scholar
  50. Lev-Ran, S., Le Strat, Y., Imtiaz, S., Rehm, J., & Le Foll, B. (2013). Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: Results from a large representative sample. The American Journal on Addictions, 22(1), 7–13.Google Scholar
  51. Lev-Ran, S., Imtiaz, S., & Foll, B. L. (2012). Self-reported psychotic disorders among individuals with substance use disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. The American Journal on Addictions, 21(6), 531–535.Google Scholar
  52. Luck, P. A., Elifson, K. W., & Sterk, C. E. (2004). Female drug users and the welfare system: A qualitative exploration. Drugs: Education, Prevention & Policy, 11(2), 113–128.Google Scholar
  53. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., & Grissom, G. (1992). The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment, 9(3), 199–213.Google Scholar
  54. Mee-Lee, D. (Ed.). (2013). The ASAM criteria: Treatment criteria for addictive, substance-related, and co-occurring conditions (3rd ed.). Chevy Chase, MD: American Society of Addiction Medicine.Google Scholar
  55. Mennis, J., & Stahler, G. J. (2016). Racial and ethnic disparities in outpatient substance use disorder treatment episode completion for different substances. Journal of Substance Abuse Treatment, 63, 25–33.Google Scholar
  56. Miller, W. R., & Tonigan, J. S. (1996). Assessing drinkers’ motivation for change: The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Psychology of Addictive Behaviors, 10(2), 81–89.Google Scholar
  57. Miquel, L., Roncero, C., García-García, G., Barral, C., Daigre, C., Grau-López, L., … Casas, M. (2013). Gender differences in dually diagnosed outpatients. Substance Abuse, 34(1), 78–80.Google Scholar
  58. Morrissey, J. P., Jackson, E. W., Ellis, A. R., Amaro, H., Brown, V. B., & Najavits, L. M. (2005). Twelve-month outcomes of trauma-informed interventions for women with co-occurring disorders. Psychiatric Services, 56(10), 1213–1222.Google Scholar
  59. Mowbray, C. T., Collins, M. E., Plum, T. B., Masterton, T., & Mulder, R. (1997). Harbinger. I: The development and evaluation of the First PACT replication. Administration and Policy in Mental Health, 25, 105–123.Google Scholar
  60. Mulvaney-Day, N., DeAngelo, D., Chen, C. N., Cook, B. L., & Alegria, M. (2012). Unmet need for treatment for substance use disorders across race and ethnicity. Drug and Alcohol Dependence, 125 Suppl 1, 44–50.Google Scholar
  61. Nagelhout, G. E., Hummel, K., de Goeij, M. C. M., de Vries, H., Kaner, E., & Lemmens, P. (2017). How economic recessions and unemployment affect illegal drug use: A systematic realist literature review. International Journal of Drug Policy, 44, 69–83.Google Scholar
  62. National Drug Intelligence Center. (2011). The economic impact of illicit drug use on American Society. Retrieved from http://www.justice.gov/ndic/
  63. Nunes, E. V., & Rounsaville, B. J. (2006). Comorbidity of substance use with depression and other mental disorders: From Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V. Addiction, 101(1), 89–96.Google Scholar
  64. Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018). Stigma at every turn: Health services experiences among people who inject drugs. International Journal of Drug Policy, 57, 104–110.Google Scholar
  65. Peirce, J. M., Brooner, R. K., King, V. L., & Kidorf, M. S. (2016). Effect of traumatic event reexposure and PTSD on substance use disorder treatment response. Drug and Alcohol Dependence, 158, 126–131.Google Scholar
  66. Preston, K. L., Silverman, K., Schuster, C. R., & Cone, E. J. (1997). Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction, 92, 717–727.Google Scholar
  67. Robins, L. N., Helzer, J. E., Croughan, J. L., & Ratcliff K. S. (1981). National Institute of Mental Health diagnostic interview schedule: Its history, characteristics, and validity. Archives of General Psychiatry, 38(4), 381–389.Google Scholar
  68. Sacks, J. J., Gonzales, K. R., Bouchery, E. E., Tomedi, L. E., & Brewer, R. D. (2015). 2010 national and state costs of excessive alcohol consumption. American Journal of Preventive Medicine, 49(5), e73–e79.Google Scholar
  69. Saitz, R. (2010). Alcohol screening and brief intervention in primary care: Absence of evidence for efficacy in people with dependence or very heavy drinking. Drug & Alcohol Review, 29(6), 631–640.Google Scholar
  70. Saitz, R., Palfai, T. A., Cheng, D. M., Alford, D. P., Bernstein, J. A., Lloyd-Travaglini, C. A., … Samet, J. H. (2014). Screening and brief intervention for drug use in primary care: The ASPIRE randomized clinical trial. Journal of the American Medical Association, 312(5), 502–513.Google Scholar
  71. SAMHSA. (2005). Medication-assisted treatment for opioid addiction in opioid treatment programs. Treatment Improvement Protocol (TIP) Series 43. HHS Publication No. (SMA) 12-4214. Rockville, MD.Google Scholar
  72. SAMHSA. (2014). The TEDS Report: Age of substance use initiation among treatment admissions aged 18 to 30. Rockville, MD.Google Scholar
  73. SAMHSA. (2015a). Screening and assessment of co-occurring disorders in the justice system. HHS Publication No. (SMA)-15-4930. Retrieved from https://store.samhsa.gov/shin/content/SMA15-4930/SMA15-4930.pdf
  74. SAMHSA. (2015b). Treatment Episode Data Set (TEDS): 2015. Discharges from substance use treatment services: Tables. Data received through March 16 (p. 2018).Google Scholar
  75. SAMHSA. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. HHS Publication No. SMA 17-5044, NSDUH Series H-52. Retrieved from https://www.samhsa.gov/data/
  76. SBIRT. (n.d.). Retrieved September 13, 2018, from https://www.integration.samhsa.gov/clinical-practice/sbirt
  77. Science of Behavior Change. (2017). The measures. In Retrieved from. https://scienceofbehaviorchange.org/measures/Google Scholar
  78. Seth, P., Scholl, L., Rudd, R., & Bacon, S. (2018). Overdose deaths involving opioids, cocaine, and psychostimulants — United States, 2015–2016. MMWR: Morbidity and Mortality Weekly Report, 67, 349–358.Google Scholar
  79. Sheehan, D. V., Lecrubier, Y., Harnett Sheehan, K., Janavs, J., Weiller, E., Keskiner, A., … Dunbar, G. C. (1997). The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. European Psychiatry, 12(5), 232–241.Google Scholar
  80. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., … Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59 Suppl 20, 22–33; quiz 34–57.Google Scholar
  81. Tanaree, A., Assanangkornchai, S., & Kittirattanapaiboon, P. (2017). Pattern and risk of developing alcohol use disorders, illegal substance use and psychiatric disorders after early onset of alcohol use: Results of the Thai National Mental Health Survey 2013. Drug and Alcohol Dependence, 170, 102–111.Google Scholar
  82. Taylor, J., Malone, S., Iacono, W. G., & McGue, M. (2002). Development of substance dependence in two delinquency subgroups and nondelinquents from a male twin sample. Journal of the American Academy of Child & Adolescent Psychiatry, 41(4), 386–393.Google Scholar
  83. Thompson, R. G., Wall, M. M., Greenstein, E., Grant, B. F., & Hasin, D. S. (2013). Substance-use disorders and poverty as prospective predictors of first-time homelessness in the United States. American Journal of Public Health, 103(S2), S282–S288.Google Scholar
  84. Tiffany, S. T., Friedman, L., Greenfield, S. F., Hasin, D. S., & Jackson, R. (2012). Beyond drug use: A systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction, 107(4), 709–718.Google Scholar
  85. Walton, M. A., Blow, F. C., Bingham, C. R., & Chermack, S. T. (2003). Individual and social/environmental predictors of alcohol and drug use 2 years following substance abuse treatment. Addictive Behaviors, 28(4), 627–642.Google Scholar
  86. Westerberg, V. S., Tonigan, J. S., & Miller, W. R. (1998). Reliability of Form 90D: An instrument for quantifying drug use. Substance Abuse, 19, 179–189.Google Scholar
  87. Williams, J., Gibbon, M., First, M., & Spitzer, R. (1992). The Structured Clinical Interview for DSM-III-R (SCID): II. Multisite test-retest reliability. Archives of General Psychiatry, 49(8), 630–636.Google Scholar

Copyright information

© Springer International Publishing AG 2019

Authors and Affiliations

  • Catherine E. Paquette
    • 1
  • Jessica F. Magidson
    • 2
  • Surabhi Swaminath
    • 1
  • Stacey B. Daughters
    • 1
    Email author
  1. 1.University of North Carolina at Chapel HillChapel HillUSA
  2. 2.University of Maryland, College ParkCollege ParkUSA

Personalised recommendations